Vivos Therapeutics
VVOS
VVOS
18 hedge funds and large institutions have $1.27M invested in Vivos Therapeutics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$445K | |
| 2 | +$64.9K | |
| 3 | +$22.2K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.75K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.57K |
Top Sellers
| 1 | -$111K | |
| 2 | -$29.8K | |
| 3 | -$787 | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$650 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$570 |
